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DESCRIPTION
An 80-year-old man was admitted to our hospital with a 2-week history of an exaggerated productive cough. He had type 2 diabetes mellitus (glycated haemoglobin 8.1%), pancreatic cancer (cT2aN0M1, stage IB) and allergic bronchopulmonary aspergillosis (ABPA) for the past few years. He was treated with antihyperglycaemic drugs and prednisolone (10 mg/day) for ABPA. No pathogens were noted on bronchial lung washing, and his condition gradually improved. However, his sputum Gram stain newly demonstrated abundant Gram-positive filamentous bacteria ( figure 1A ). Furthermore, 48 h after incubation of sputum with 5% sheep's blood agar (Eiken Chemical, Tokyo, Japan) at 37°C under 5% CO 2 , smooth, very small white colonies appeared and when mature they were rough, dry, folded convex and adhered to the blood agar; these were identified as Rothia aeria using Matrix-Assisted Laser Desorption/Ionisation-Time of Flight Mass Spectrometry (MALDI-Tof-MS). R. aeria was first isolated from an air and water sampler in Russia's Mir space station 1 and has been detected in the mouths of healthy individuals. 2 It can be mistaken for Nocardia spp (figure 1B, presented as control) due to the morphological similarities, and discrimination between R aeria and Nocardia spp needs further analyses, such as MALDI-Tof-MS and/or 16S rRNA. R. aeria rarely causes respiratory infections, 3 but it should be considered in the differential diagnosis of Nocardia spp, especially in immunocompromised patients who are vulnerable to Nocardia infections.
Learning points
▸ Rothia aeria is a Gram-positive filamentous bacterium that can colonise in healthy individuals. ▸ R. aeria rarely causes respiratory infections, but it should be differentiated from Nocardia spp. ▸ The discrimination between Nocardia spp and Rothia aeria needs further analyses using MALDI-Tof-MS and/or 16S rRNA. 
